Skip to main content

Table 3 Answers to question 6 of the survey: radiopharmaceuticals in clinical use in European countries.

From: Multimodality imaging in Europe: a survey by the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM)

  ESR EANM
18F-Fluoro-2-deoxy-D-glucose (FDG) 73% 99%
18F-Dopa 10% 29%
18F-Fluorocholine 10% 23%
18F-Fluoroethyl-L-tyrosine (FET) 5% 12%
18F-Fluorothymidine (FLT) 4% 14%
Other 18F 4% 12%
Any 11C 2% 14%
Rubidium-82 1% 6%
15O-Water 1% 11%
Others 7% 13%